| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 01/30/2008 | CN100364997C Vinorelbine preparation method |
| 01/30/2008 | CN100364996C Purification method of catharanthine and vincristine |
| 01/30/2008 | CN100364992C A class of pyrrolo-naphthyridine derivatives |
| 01/29/2008 | US7323569 N-cyclopropylmethyl-N-7-[2,6-dimethoxy-4-(methoxymethyl)phenyl]-2-ethylpyrazolo[1,5-a]pyridin-3-yl-N-tetrahydro-2H-4-pyranylmethylamine. |
| 01/29/2008 | US7323568 Heating 4-chloro-1-isobutyl-1H-imidazo[4,5-c]-quinoline in formamide, bubbling with gaseous ammonia; purifying; highly pure form from crystallization |
| 01/29/2008 | US7323567 RSV polymerase inhibitors |
| 01/29/2008 | US7323487 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 01/29/2008 | US7323486 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 01/29/2008 | US7323474 Pyridine derivatives inhibiting angiogenesis and/or VEGF receptor tyrosine kinase |
| 01/29/2008 | US7323473 Administering (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine; serotonin receptor antagonists (5HT/5HT2C) for treatment of obesity |
| 01/29/2008 | US7323472 Antiarthritic agents; sepsis shock; malaria; antiischemic agents; respiratory system disorders; brain disorders; congestive heart failure |
| 01/29/2008 | US7323468 as modulators of receptor tyrosine kinases and cytoplasmic tyrosine and serine/threonine kinases; can bind both to active and also to non-active kinases and therefore influence the signal transduction |
| 01/29/2008 | US7323460 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamides useful as HIV integrase inhibitors |
| 01/29/2008 | CA2226058C 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives |
| 01/24/2008 | WO2008011521A2 Polycyclic viral inhibitors |
| 01/24/2008 | WO2008011109A2 Substituted pyridone compounds and methods of use |
| 01/24/2008 | WO2008011032A1 Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors |
| 01/24/2008 | WO2008010964A1 1-hydroxy naphthyridine compounds as anti-hiv agents |
| 01/24/2008 | WO2008009908A1 Pyrido [2, 3-b] pyrazine derivatives useful as herbicidal compounds |
| 01/24/2008 | WO2008009735A1 Pyrazolo (3, 4-b) pyridine derivatives as pde4 inhibitors |
| 01/24/2008 | WO2008009215A1 Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof |
| 01/24/2008 | WO2008009125A1 Tetrahydro-5h-pyrido[2,3-d]azepines as 5-ht2c ligands |
| 01/24/2008 | WO2008009122A1 Acrylamide derivatives as fab i inhibitors |
| 01/24/2008 | WO2007140383A3 Spirocyclic sulfonamides and related compounds |
| 01/24/2008 | WO2007123953A3 Phosphodiesterase 4 inhibitors |
| 01/24/2008 | WO2007103719A3 MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| 01/24/2008 | WO2007072507A3 Polymorphic forms of dolasetron base and processes of preparing dolasetron base, its polymorphic forms and salt thereof |
| 01/24/2008 | WO2007001975A8 Piperidine derivatives useful as histamine h3 antagonists |
| 01/24/2008 | US20080021220 Naphthalene-based semiconductor materials and methods of preparing and use thereof |
| 01/24/2008 | US20080021061 Tetrahydropyranyl Cyclopentyl Tetrahydropyridopyridine Modulators of Chemokine Receptor Activity |
| 01/24/2008 | US20080021060 Quinuclidine carbamate derivatives and their use as M3 antagonists |
| 01/24/2008 | US20080021059 Antibacterial Agents |
| 01/24/2008 | US20080021058 Pyrazolo '3,4-B! Pyridine Compounds And Their Use As Phosphodiesterase Type 4(Pde4) Inhibitors |
| 01/24/2008 | US20080021057 3-Trifluoromethyl,6-((3-(methyl,4-hydroxytetrahydropyran-4-yl)-amino-(3-isopropyl-cyclopent-1,3-ylene))-carbonyl-)-5,6,7,8-tetrahydro-1,6-naphthyridine; antiinflammatory agents; immunomodulators; antiallergens; rhintis; dermatitis; conjunctivits, asthma; autoimmune diseases; antiarthritis agents |
| 01/24/2008 | US20080021056 Fused, Tricyclic Sulfonamide Inhibitors of Gamma Secretase |
| 01/24/2008 | US20080021050 Compounds, compositions, and methods |
| 01/24/2008 | US20080021043 Piperidines and Related Compounds for Treatment of Alzheimer's Disease |
| 01/24/2008 | US20080021039 2-[2-(4-Methoxypyridin-2-yl)ethyl]-6-[4-(4-methylpiperazin-1-yl-sulfonyl)-phenyl]-3H-imidazo-[4,5-b]pyridine,; acute inflammatory diseases: Septic shock, sepsis, SIRS, hemorrhagic shock, organ transplantation and transplant rejection, head trauma, acute lung injury |
| 01/24/2008 | US20080021037 Isethionate salt of a selective cdk4 inhibitor |
| 01/24/2008 | US20080020986 mimetics of the activity of the N-terminal portion of Smac/tertiary binding structure to IAPs, can be combined with chemotherapeutic agents like topoisomerase inhibitors, kinase inhibitors, NSAIDs, taxanes and platinum containing compounds; increased cell permeability, water solubility; antitumor agents |
| 01/24/2008 | US20080019942 Novel inhibitors of hepatitis c virus replication |
| 01/24/2008 | US20080017850 applying n-type organic semiconducting compound 1,6,7,12-Tetrachloro-N,N'-benzyl-perylene-3,9; 11,12-tetracarboxylic diimide or 1,6,7,12-tetrachloroperylen-3,9; 9,10-tetracarboxylic dianhydride; charge transfer compounds for electronics, optoelectronics and photonic applications; chemical intermediates |
| 01/24/2008 | CA2692440A1 Tetrahydro-5h-pyrido[2,3-d]azepines as 5-ht2c ligands |
| 01/24/2008 | CA2658764A1 Benzothiophene inhibitors of rho kinase |
| 01/24/2008 | CA2658506A1 Acrymalide derivatives as fab 1 inhibitors |
| 01/24/2008 | CA2658376A1 4-heteroaryl-substituted 1-aminocyclohexane-1- and cyclohexane-1-derivatives having effects of the opioid receptor system |
| 01/24/2008 | CA2657788A1 Polycyclic viral inhibitors |
| 01/24/2008 | CA2657287A1 1-hydroxy naphthyridine compounds as anti-hiv agents |
| 01/24/2008 | CA2657282A1 Pyrido [2,3-b] pyrazine derivatives useful as herbicidal compounds |
| 01/23/2008 | EP1880996A1 Spiroindolinepiperidine derivatives |
| 01/23/2008 | EP1880993A1 Nitrogen-containing heterocyclic compound |
| 01/23/2008 | EP1879895A1 Enzyme inhibitors |
| 01/23/2008 | EP1879893A1 Method for making 1-substituted 1h-imidazo[4,5-c]quinolin-4-amine compounds and intermediates therefor |
| 01/23/2008 | EP1879892A2 2-pyrrolidone derivatives and their uses for the treatment of inflammatory conditions and pain |
| 01/23/2008 | EP1879891A1 Mutual prodrug compounds for use as antiinflammatory agents with gastrointestinal protective activity |
| 01/23/2008 | EP1879890A1 Preparation of aseptic 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4h-pyridio[1,2-a]pyrimidin-4-one palmitate ester |
| 01/23/2008 | EP1879889A1 Process for making fluorinated 4-azasteroid derivatives and intermediate thereof |
| 01/23/2008 | EP1879887A2 Npy antagonists, preparation and use |
| 01/23/2008 | EP1879886A1 Mitotic kinesin inhibitors and methods of use thereof |
| 01/23/2008 | EP1879847A1 Terrylene and quaterrylene derivatives |
| 01/23/2008 | EP1879591A1 Use of azapaullones for preventing and treating pancreatic autoimmune disorders |
| 01/23/2008 | EP1879577A1 Proton pump inhibitors in the treatment of sleep disturbance due to silent gastro-esophageal reflux |
| 01/23/2008 | EP1879564A2 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus |
| 01/23/2008 | EP1879548A2 Process for coloring keratin fibers comprising metal complexes |
| 01/23/2008 | EP1799679B1 N,n'-dithenylurea derivatives suitable as kinase inhibitors |
| 01/23/2008 | EP1768985B1 Pyrimido-benzimidazole derivatives and the use thereof in the form of agonists or antagonists of melanocortin receptors |
| 01/23/2008 | EP1725569B1 Prodrugs of piperazine and substituted piperidine antiviral agents |
| 01/23/2008 | EP1569934B1 Cyclopropyl compounds as ccr5 antagonists |
| 01/23/2008 | EP1551828B1 Pyrazole derivatives |
| 01/23/2008 | EP1490366B1 alkoxypyridine-derivatives |
| 01/23/2008 | EP1432313B1 N-thio-nicotinamide derivatives and related compounds for use as pesticides |
| 01/23/2008 | EP1322651B1 Bicyclic heteroaromatic compounds |
| 01/23/2008 | CN101111495A Crystalline 1h-imidazo[4,5-b]pyridin-5-amine, 7-[5-[(cyclohexylmethylamino)-methyl]-1h-indol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its pharmaceutical uses |
| 01/23/2008 | CN101111494A Therapeutic pyrazolo[3,4-b]pyridines and indazoles |
| 01/23/2008 | CN101108825A Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists |
| 01/23/2008 | CN100363348C PgD2 receptor antagonists for the treatment of inflammatory diseases |
| 01/22/2008 | US7321041 1,6 Naphthyridines useful as inhibitors of SYK kinase |
| 01/22/2008 | US7321040 MAP (mitogen-activated protein) kinase inhibitors; osteoarthritis, rheumatoid arthritis, anticarcinogenic or antiischemic agents; reperfusion injuries, strokes or heart attack; autoimmune, skin, cardiovascular, brain, bone, neurodegenerative, respiratory system and nervous system disorders |
| 01/22/2008 | US7321033 Having immunomodulatory activity; for therapy and prophylaxis of infections caused by adenovirus, cytomegalovirus, hepatitis A virus (HAV), hepatitis B virus (HBV), flaviviruses including Yellow Fever virus, herpes virus |
| 01/22/2008 | US7320995 Lung melanoma metastasis, rheumatoid arthritis, 1-isopropylsulfonyl-2-amino-6-(2-(2,6-difluorophenyl)-5-(phenyl)-imidazol-4-yl)-benzimidazole |
| 01/22/2008 | US7320993 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic useful as cytostatic and immuosuppressive agents |
| 01/22/2008 | US7320987 2,6-disubstituted 7-oxo-pyrido[2,3-d]pyrimidines; inhibition of LPS-induced Tumor Necrosis Factor- alpha production in THP1 cells |
| 01/22/2008 | US7320981 Variolin derivatives as anti-cancer agents |
| 01/22/2008 | US7320980 Substituted pyrido(1,2-a)pyrimidines and their use as NOS inhibitors |
| 01/22/2008 | CA2309629C Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters |
| 01/22/2008 | CA2305807C Substituted fused heterocyclic compounds |
| 01/22/2008 | CA2281721C Phthalazines with angiogenesis inhibiting activity |
| 01/17/2008 | WO2008008539A2 Fused heterocyclic derivatives useful as inhibitors of the hepatocyte growth factor receptor |
| 01/17/2008 | WO2008006795A2 Indole compounds |
| 01/17/2008 | WO2008006702A1 11beta-hydroxysteroid dehydrogenase type 1 active compounds |
| 01/17/2008 | WO2008006540A1 Triazolopyridine derivatives as herbicides |
| 01/17/2008 | WO2007134259A3 Compounds and compositions as protein kinase inhibitors |
| 01/17/2008 | WO2007114922A3 Salts of 8-[{1-(3,5-bis-(trifluoromethyl) phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor |
| 01/17/2008 | WO2007081907A3 Crystalline forms of dolasetron base and processes for preparation thereof |
| 01/17/2008 | WO2007075297A3 Muscarinic agonists and methods of use thereof |
| 01/17/2008 | US20080015220 Biphenyl-2-ylcarbamic acid 1-{7-[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]heptyl}piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist; bronchodilator agent; pulmonary disorders, chronic obstructive pulmonary disease and asthma |
| 01/17/2008 | US20080015219 Treating eye diseases including glaucoma or ocular hypertension; selective prostaglandin EP2 agonists; acid-functional aryl substituted cyclopentanone or hydroxycyclopentane compounds |
| 01/17/2008 | US20080015214 3-piperidin-4-yl-indole orl-1 receptor modulators |
| 01/17/2008 | US20080015212 Inhibitors Of Akt Activity |
| 01/17/2008 | US20080015201 3-(Phenylsulfonyl)-7-piperazin-1-yl-1H-pyrazolo[4,3-b]pyridine; 5-HT receptor subtype 5HT6; selective serotonin receptor antagonist; cognition actiators; alzheimer's disease; attention deficit disorder; antidepressant; antiepileptic agent; anxiolytic agents; obsessive compulsive disorder; Parkinson's |